$PRAN Headlines U.S. stocks rise; S&P 500, Nas

$PRAN Headlines

U.S. stocks rise; S&P 500, Nasdaq notch quarterly gains 3:47 p.m. March 31, 2014 - Anora Mahmudova
Keurig biggest S&P 500 loser; BlackBerry extends losses 2:30 p.m. March 31, 2014 - Sue Chang
Biotech's shares fall 70% on tests 11:39 a.m. March 31, 2014 - Russ Britt
U.S. stock futures extend gains ahead of Yellen 7:58 a.m. March 31, 2014 - Barbara Kollmeyer
U.S.-listed shares of Prana sink after drug trial 6:50 a.m. March 31, 2014 - Saumya Vaishampayan
Prana sinks 62% after Alzheimer's study fails 6:22 a.m. March 31, 2014 - Barbara Kollmeyer
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:11 p.m. Feb. 18, 2014 - Sue Chang
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Prana's wild ride continues with shares surging on drug test results 3:24 p.m. Feb. 18, 2014 - Russ Britt
Prana's Huntington disease therapy meets endpoints 11:51 a.m. Feb. 18, 2014 - MarketWatch.com
Prana Biotechnology up 19% in premarket 8:58 a.m. Dec. 6, 2012 - Steve Gelsi
Prana has OK for Alzheimer's study; shares rise 1:30 p.m. Nov. 22, 2011 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:30 p.m. Sept. 19, 2011 - Laura Mandaro
Prana, European drug makers lead rally 2:26 p.m. April 20, 2011 - Val Brickates Kennedy
Prana climbs 14% on business update 10:18 a.m. April 20, 2011 - Val Brickates Kennedy
Xoma, Prana lead biotech stocks south 12:19 p.m. March 23, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 3:56 p.m. March 22, 2011 - Kate Gibson
Prana shines in drugstock trading 10:02 a.m. March 22, 2011 - Val Brickates Kennedy
Prana rockets on Alzheimer's study 9:20 a.m. March 22, 2011 - Val Brickates Kennedy


Genervon ALS drug shows encouraging results 7:27 a.m. Oct. 20, 2014 - Seeking Alpha
Horizon Pharma's Actimmune Gets Orphan Drug Designation - Analyst Blog 1:00 p.m. Oct. 7, 2014 - Zacks.com
Prana Biotechnology Up on Orphan Drug Status for PBT2 - Analyst Blog 4:35 p.m. Sept. 8, 2014 - Zacks.com
Why Prana Biotechnology (PRAN) Stock Is Surging Today 8:46 a.m. Sept. 5, 2014 - TheStreet.com
Why Prana Biotechnology (PRAN) Stock Is Surging Today 1:05 p.m. July 17, 2014 - TheStreet.com
Prana shares up premarket on clinical trial update 8:22 a.m. July 17, 2014 - Seeking Alpha
Prana Biotechnology (PRAN) Stock Suddenly Surges 2:28 p.m. May 27, 2014 - TheStreet.com
Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure 3:15 p.m. April 14, 2014 - Seeking Alpha
Are These Three Biotech Companies Still Worth A Gamble? 10:16 a.m. April 14, 2014 - Seeking Alpha
Prana collapses after trial fails 5:57 a.m. March 31, 2014 - Seeking Alpha
Prana Biotechnology - A Gamble Worth Taking For Both Long- And Short-Term Investors 2:49 p.m. March 20, 2014 - Seeking Alpha
Prana to join Aussie index for top 300 companies 9:00 a.m. March 11, 2014 - Seeking Alpha
Alzheimer's Research Stocks - Technical And Other Considerations 8:38 a.m. March 7, 2014 - Seeking Alpha
Prana Biotech Alzheimer approach supported by study 10:49 a.m. March 6, 2014 - Seeking Alpha
Alzheimer's Dementia: Eli Lilly's Solanezumab Or Prana's PBT2, Which Would You Take? 3:24 p.m. March 4, 2014 - Seeking Alpha
Prana: Right Drug, Wrong Dose 9:38 a.m. March 3, 2014 - Seeking Alpha
Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results 6:45 a.m. March 1, 2014 - Seeking Alpha
Following The Latest In Alzheimer's Research As An Investor 10:12 a.m. Feb. 24, 2014 - Seeking Alpha
Positive Phase 2 Results For Prana Biotechnology In Huntington's Disease: Behind The Smoke And Mirrors 12:45 p.m. Feb. 22, 2014 - Seeking Alpha
SA PRO: Top Long And Short Ideas, Thursday February 20 7:30 a.m. Feb. 21, 2014 - Seeking Alpha


The Lancet Neurology Publishes Prana's Huntington Disease Trial 11:01 a.m. Today - BusinessWire - BZX
Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma 8:15 a.m. Sept. 11, 2014 - PR Newswire - PRF
Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease 6:45 a.m. Sept. 5, 2014 - PR Newswire - PRF
Prana Alzheimer's disease Development Program update 3:10 p.m. July 17, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics 6:04 a.m. July 14, 2014 - PR Newswire - PRF
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals 4:10 a.m. July 14, 2014 - PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on Isis Pharma, Pharmacyclics, Amarin, and Prana Biotechnology 6:10 a.m. June 11, 2014 - PR Newswire - PRF
Biotech Equities Coverage -- Research on Isis Pharma, Pharmacyclics, Prana Biotech, and United Therapeutics 10:29 a.m. May 19, 2014 - PR Newswire - PRF
World leader in movement disorders Professor Ira Shoulson joins Prana Board 6:30 a.m. May 14, 2014 - PR Newswire - PRF
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games 10:34 a.m. April 23, 2014 - PR Newswire - PRF
Zeldes Haeggquist & Eck LLP Announces Investigation of Prana Biotechnology Limited 8:03 a.m. April 23, 2014 - BusinessWire - BZX
Prana Biotechnology Stock Hits New Low 9:47 a.m. April 16, 2014 - ACCESSWIRE
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin 8:49 a.m. April 2, 2014 - ACCESSWIRE
Coca-Cola Falls as Soda Sales Drop for 9th Straight Year 1:00 a.m. April 1, 2014 - ACCESSWIRE
Prana Biotechnology announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease 6:05 a.m. March 31, 2014 - PR Newswire - PRF
Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health 11:19 a.m. March 28, 2014 - PR Newswire - PRF
Huntington's Reviewed by NeuroPerspective 8:30 a.m. March 4, 2014 - PR Newswire - PRF
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results 12:23 a.m. Feb. 19, 2014 - ACCESSWIRE
Prana Meets Primary Endpoint in Phase 2 REACH2HD Clinical Study of PBT2 for Treating Huntington Disease 6:02 a.m. Feb. 18, 2014 - PR Newswire - PRF
Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 8:00 a.m. Dec. 20, 2013 - PR Newswire